In this special episode of the View, Dr. Peter Block and Dr. Anthony DeMaria discuss highlights from Day 4 of TCT.19, including the cost-effectiveness analysis from MitraClip in heart failure and severe secondary mitral regurgitation (COAPT Cost-Effectiveness Analysis) and health status outcomes from transcatheter aortic valve replacement vs. surgical aortic valve replacement in severe aortic stenosis patients at low-surgical risk (PARTNER 3).

Subscribe on iTunes | Subscribe on Google Play

Clinical Topics: Cardiac Surgery, Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Valvular Heart Disease, Aortic Surgery, Cardiac Surgery and Heart Failure, Cardiac Surgery and VHD, Acute Heart Failure, Interventions and Imaging, Interventions and Structural Heart Disease, Angiography, Nuclear Imaging, Mitral Regurgitation

Keywords: EaglesEyeView, TCT19, Transcatheter Cardiovascular Therapeutics, Angiography, Aortic Valve, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis, Percutaneous Coronary Intervention, Angiography, Mitral Valve Insufficiency, Cost-Benefit Analysis, Heart Failure, Heart Valve Prosthesis Implantation, Percutaneous Coronary Intervention

< Back to Listings